Understanding the quality-of-life impact of SPMS along with patient desired outcomes can help neurologists develop the most effective approach to treating patients for whom MS is advancing.
Multiple sclerosis (MS) is a progressive disease that can have a devastating impact on quality of life. As MS progresses to secondary, the toll on quality of life and physical abilities becomes more acute.
Research was undertaken to ascertain unique differences between those with secondary progressive (SPMS) versus relapsing remitting (RRMS) MS, including day to day life, medication regimen and treatment goals.